Clinical Trial

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main objective of this trial is to investigate relative bioavailability of BI 456906 reference formulation (Formulation A) vs. BI 456906 test formulation (Formulation B2).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-07-16; most recent amendment 2026-03-12.
Status change: Active, Not Recruiting → Completed 2025-11-18
Status change: Recruiting → Active, Not Recruiting 2025-09-01
Status change: Not Yet Recruiting → Recruiting 2025-08-04
Trial Details
NCT Number NCT07071974
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 16 participants
Start Date 2025-07-28
Primary Completion 2025-10-07 (estimated)
Study Completion 2025-10-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-13